Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan

Details for Australian Patent Application No. 2009321249 (hide)

Owner Sanofi

Inventors Lejeune, Pascale; Vrignaud, Patricia

Agent A J Park

Pub. Number AU-A-2009321249

PCT Pub. Number WO2010/061357

Priority 08291116.5 28.11.08 EP

Filing date 27 November 2009

Wipo publication date 3 June 2010

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 31/00 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

9 June 2011 Alteration of Name

  The name of the applicant has been altered to Sanofi

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/061357 Priority application(s): WO2010/061357

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009321250-Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine

2009321245-Queuing mechanisms for LTE access and SAE networks enabling end-to-end IMS based priority service